One phase III trial was published in 2022 regarding the use of tirzepatide on overweight and obese patients without diabetes, known as the SURMOUNT trial
N-Acetyl Glucosamine (NAG) A barrier-supporting, gentle, skin-refiner that smooths the look of pores while helping to increase the skins own natural hyaluronic acid levels over time
My position is simple: most grown adults, when given complete and honest information about risks, benefits, monitoring requirements, and alternatives, are capable of making decisions about their own bodies
Both work completely differently
Tirzepatide enhanced functional ability, quality of life and reduced the risk of worsening HF events in obese patients with HFpEF, with benefits observed even among those with chronic kidney disease, according to the SUMMIT trial
But in the absence of science, its hard to recommend these medications [for ADHD], especially without safety reviews in these patients. Is it dangerous for people with ADHD to take GLP-1s